BofA Securities Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy

January 5, 2023 6:20 AM

BofA Securities analyst Geoff Meacham initiates coverage on Amylyx Pharmaceuticals inc. (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found